Therefore, HDACs are considered as potential therapeutic targets, and the development of HDAC inhibitors (HDACi), antagonizing tumor initiation and/or growth, is a promising topic in the search for new anticancer drugs [28]. The gene discussed is HDAC9; the disease is neoplasm.